MedPath

PACT: Prevention of Atopy among Children in Trondheim

Completed
Conditions
Atopic and allergic diseases in early childhood
atopic eczema
allergic rhinoconjunctivitis
asthma
Signs and Symptoms
Registration Number
ISRCTN28090297
Lead Sponsor
orwegian University of Science and Technology (Norway)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
14000
Inclusion Criteria

All pregnant women living in the community of Trondheim, Norway willing to complete repeated questionnaires on risk factors and disease during pregnancy and until their child was 6 years of age could be included in the study

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Self-reported changes in risk factor exposure and behaviour reported in repeated questionnaires in pregnancy, 6 weeks postnatal an at 1 and 2 and 6 years after birth
Secondary Outcome Measures
NameTimeMethod
Changes in prevalence of atopic disease when the child was 2 years of age and 6 years of age
© Copyright 2025. All Rights Reserved by MedPath